Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
Slobodan M JankovicPharmacology Department, Medical Faculty, University of Kragujevac, Kragujevac, SerbiaAbstract: Multiple sclerosis (MS) is chronic inflammatory and demyelinating disease with either a progressive (10%–15%) or relapsing-remitting (85%–90%) course. The pa...
Saved in:
Main Author: | Slobodan M Jankovic |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/5b85b4be0c234d4daefdbd2f0a9208a1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients [Corrigendum]
by: Taheri M, et al.
Published: (2019) -
Alemtuzumab in the treatment of multiple sclerosis
by: Fernandez Ó
Published: (2014) -
Emerging therapies for treatment of multiple sclerosis
by: John R Corboy, et al.
Published: (2010) -
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
by: Afsaneh Shirani, et al.
Published: (2010) -
Vascular involvement in systemic sclerosis (scleroderma)
by: Pattanaik D, et al.
Published: (2011)